Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Wisconsin School of Medicine and Public Health, University of Wisconsin Carbone Cancer Center, University of Wisconsin Hospital and Clinics, the University of Wisconsin-Madison School of Nursing, Continuing Education in Nursing and the Wisconsin Cancer Council. The University of Wisconsin School of Medicine and Public Health is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Wisconsin School of Medicine and Public Health designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

This activity has been planned and implemented using the educational design criteria of the American Nurses Credentialing Center's Commission on Accreditation through the joint providership of the University of Wisconsin-Madison School of Nursing, Continuing Education in Nursing and the above partners.

The University of Wisconsin-Madison School of Nursing, Continuing Education in Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

The University of Wisconsin-Madison School of Nursing, Continuing Education in Nursing is Iowa Board of Nursing provider 350.

The University of Wisconsin-Madison School of Nursing, Continuing Education in Nursing designates this live activity for a maximum of 5.8 ANCC contact hours (7 Iowa contact hours).

Continuing Education Units

The University of Wisconsin-Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for 0.55 Continuing Education Units (CEUs) or 5.5 hours.

Far too many cancers do not have a proven means of prevention or effective treatments. We must gain better insights into the biological, environmental, and behavioral influences on these cancers to make a difference for the millions of Americans who suffer from them.

Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.

This activity is designed for individuals who are involved in cancer treatment and education of cancer patients and their families: oncology physicians, primary care physicians, oncology nurses, nurse practitioners, clinical research associates, health educators, social workers, psychologists, chaplains and other interested health care professionals involved in cancer care. Patients, caregivers and community members are also encouraged to attend.

This CME/CNE activity has been designed to change learner competence and focuses on the American Board of Medical Specialties areas of patient care and procedural skills, interpersonal and communications skills and professionalism.

This activity is designed to educate physicians, nurses and other health care providers about issues related to patient-centered cancer care. Learning objectives for this conference include:

• Describe the scientific challenges that remain for successfully implementing precision oncology strategies and the hope that precision medicine provides for patients.
• Explore the use of a holistic wellness goal setting tool to personalize various survivorship care plan templates.
• Discuss strategies for determining who benefits most from therapies and genetic screening in the maintenance and/or surveillance phase.
• Delineate the principles of delivering patient- and family-centered cancer care.
• Identify biological, psychological and social factors relevant to personalized symptom management.
• Discuss targeted and tailored interventions for cancer pain and co-occurring symptoms.
• Identify the challenges and opportunities in using genomics for precision medicine in oncology.
• Recognize the critical importance of vulnerability through introspection, risk and the necessity of connection.
• Identify three keystones to successfully implement oncology rehabilitation
• Describe the benefits and limitations of the new multi-gene panel options for hereditary cancer genetic testing and risk assessment
• Understand the advancements and techniques used to individualize radiotherapy for cancer patients

• Recognize some of the intricate features and difficulties of doctor-patient communication and provide ways to identify areas where improvement is needed and possible, and most importantly, pinpoint starting points for enacting those changes

• Identify implementation strategies and challenges to define, screen and address distress in patients with cancer.

• Understand existing research for breast cancer treatment decision-making and challenges to studying and improving this decision process for patients.

It is the policy of the University of Wisconsin Schools of Medicine and Public Health and Nursing that the faculty, authors, planners and other persons who may influence content of this CME/CNE activity disclose all relevant financial relationships with commercial interests in order to allow CME/CNE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosures will be made in the activity handout materials.